Bertolasi C A, Tronge J E, Riccitelli M A, Villamayor R M, Zuffardi E
Chest. 1976 Nov;70(5):596-605. doi: 10.1378/chest.70.5.596.
In order to establish the natural evolution of unstable angina under medical treatment and to determine the possible benefits of revascularization surgery, 113 patients were studied; 51 received medical treatment (24 with intermediate syndrome and 27 with progressive angina), and 62 others received surgical treatment (28 with intermediate syndrome and 34 with progressive angina). After a mean follow-up of 32 months, the mortality in the medically treated groups was 46 percent (11/24) with intermediate syndrome and 7 percent (2/27) with progressive angina (P less than 0.005), and the incidence of myocardial infarction was 38 percent (9/24) and 7 percent (2/27), respectively (P less than 0.01). Moreover, in comparing cases treated medically or surgically, the mortality was as follows: intermediate syndrome treated medically, 46 percent (11/24) vs 11 percent (3/28) in those treated surgically (P less than 0.005); and progressive angina treated medically, 7 percent (2/27) vs 9 percent (3/34) in those treated surgically (P = 0.85). The incidence of myocardial infarction was as follows: intermediate syndrome treated medically, 38 percent (9/24) vs 14 percent (4/28) in those treated surgically (P less than or equal to 0.056); and progressive angina treated medically, 7 percent (2/27) vs 12 percent (4/34) in those treated surgically (P greater than 0.55).
为了确定不稳定型心绞痛在药物治疗下的自然转归,并确定血运重建手术可能带来的益处,对113例患者进行了研究;51例接受药物治疗(24例为中间综合征,27例为进行性心绞痛),另外62例接受手术治疗(28例为中间综合征,34例为进行性心绞痛)。平均随访32个月后,药物治疗组中,中间综合征患者的死亡率为46%(11/24),进行性心绞痛患者的死亡率为7%(2/27)(P<0.005),心肌梗死发生率分别为38%(9/24)和7%(2/27)(P<0.01)。此外,比较药物治疗和手术治疗的病例,死亡率如下:药物治疗的中间综合征患者为46%(11/24),手术治疗的患者为11%(3/28)(P<0.005);药物治疗的进行性心绞痛患者为7%(2/27),手术治疗的患者为9%(3/34)(P=0.85)。心肌梗死发生率如下:药物治疗的中间综合征患者为38%(9/24),手术治疗的患者为14%(4/28)(P≤0.056);药物治疗的进行性心绞痛患者为7%(2/27),手术治疗的患者为12%(4/34)(P>0.55)。